Harris Williams has named Dr. Julian Feneley as a managing director of healthcare and life sciences. Most recently, he was managing director and head of healthcare Europe at Macquarie Capital.
RICHMOND, Va. – January 20, 2022 – Harris Williams, a global investment bank specializing in M&A advisory services, today announced that Dr. Julian Feneley has joined the firm’s London office as Managing Director, Healthcare & Life Sciences (HCLS). Dr. Feneley brings close to 30 years of healthcare and life sciences industry experience to Harris Williams, and will lead HCLS’s European efforts, building on the firm’s expertise across the group’s key verticals, including pharma services, medical devices, and numerous healthcare provider segments.
“We are excited to welcome Julian to Harris Williams as we continue to expand our global platform,” said Bob Baltimore and John Neuner, co-heads of M&A at Harris Williams. “As a seasoned and trusted advisor and proven industry executive, Julian brings an extensive understanding of the healthcare landscape and universe of sponsors and corporates globally that is critical to navigating an increasingly active and dynamic sector. Moreover, Julian values our firm’s culture of collaboration and integrity, and we look forward to his many contributions as we further strengthen our ability to meet increasing client demand across Europe.”
“Harris Williams has an outstanding reputation of unlocking value for its clients, and I’m delighted to join its insightful and dedicated team at this exciting time in the firm’s growth,” said Dr. Feneley. “I look forward to collaborating with my new colleagues as the firm continues to build its global presence.”
Cheairs Porter and Geoff Smith, co-heads of Harris Williams’ Healthcare & Life Sciences Group, added, “The sustained, robust expansion of healthcare and life sciences globally demands the deep industry relationships, expertise, and execution capabilities that Julian brings to our growing European business. We believe our unrivalled sector knowledge and unwavering commitment to client service uniquely positions us to guide our corporate and financial sponsor clients as they seek to capitalize on attractive opportunities around the world.”
Dr. Feneley was most recently Managing Director and Head of Healthcare Europe at Macquarie Capital (investment banking division of Macquarie Group). Previous experience includes serving as Head of Healthcare Investment Banking Europe at Canaccord Genuity Inc. after leading healthcare investment banking in Europe at JP Morgan. He also served as CEO of BriteSmile Inc, a leading US dental technology company that served more than 7,000 dental practice clients worldwide. Dr. Feneley earned MBBS (medical) and B.Sc (science) degrees from the University of London (Guy’s Hospital).
Harris Williams’ HCLS Group is dedicated to understanding the complex industry dynamics and providing superior merger and acquisition advisory services to companies that operate within it. The HCLS Group has deep experience across a broad range of sectors, including healthcare providers, payors and payor services, outsourced pharmaceutical services, medical device supply chain, healthcare IT, and pharmacy.
For more information on Harris Williams’ HCLS Group, please visit: https://www.harriswilliams.com/industries/healthcare-and-life-sciences.
About Harris Williams
Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).